News and Trends 8 Jun 2022Synklino raises €29.8M to trial cytomegalovirus drug Danish biotech Synklino has completed a Series A fundraising round that netted €29.8M ($31.8M). The company is developing drugs for… June 8, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email